Rahul R. Parikh, MD,MBA

I am a Board-Certified Radiation Oncologist in the Department of Radiation Oncology at the Rutgers Cancer Institute of New Jersey and a Professor at the Rutgers Robert Wood Johnson Medical School (RWJMS). I graduated Magna Cum Laude from an accelerated physician-scientist (BS/MD) program from Rensselaer Polytechnic Institute. I then went on to receive my medical degree from Albany Medical College in Albany, New York where I graduated with a distinction in research. Soon after, I returned to my home state of New Jersey and went on to complete my internship in Internal Medicine at Robert Wood Johnson Medical School. I continued my residency in Radiation Oncology at Robert Wood Johnson Medical School / Rutgers Cancer Institute of New Jersey where I held the title of Chief Resident Physician.

Prior to joining the faculty at Rutgers Cancer Institute of New Jersey, I was appointed Assistant Professor of Radiation Oncology at the Icahn School of Medicine at Mount Sinai in New York City. I specialized in the treatment of Lymphoma / Hematologic Malignancies and Brain tumors – both benign and malignant. With my experience at Mount Sinai,

I also had the opportunity to conduct several clinical trials and present and co-author numerous clinical and translational papers in the oncology literature. My clinical and academic interests were to use integrate patient reported outcomes to improve cancer care delivery and the health-related quality of life of cancer patients. I also optimized the use of intensity-modulated radiation therapy (IMRT), stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), and proton beam therapy (PBT) in the management of my cancer patients.

In 2013, I was appointed as Director of the Proton Beam Therapy for the Mount Sinai Health System. With this position, I helped to integrate the use of proton therapy into the multidisciplinary oncology treatment programs within the cancer center. At Rutgers Cancer Institute of New Jersey and RWJUH I serve as the Medical Director, Laurie Proton Therapy Center. My primary research and clinical focus is in lymphoma / hematologic malignancies, genitourinary malignancies and several disease sites using proton beam therapy (including pediatrics, skull base tumors, brain tumors-benign and malignant). I am also involved in specialized treatment modalities including Image-guided Radiation Therapy and Tomotherapy for select cases. I have a strong research interest in the outcomes of patients treated with advanced radiotherapy modalities, such as proton therapy. In addition to my clinical and academic practice at Rutgers Cancer Institute of New Jersey, I hold several leadership roles within committees in ASTRO (American Society for Therapeutic Radiation Oncology), on the steering committee of the International Lymphoma Radiation Oncology Group (ILROG), and on several committees of the Particle Therapy Co-Operative Group (PTCOG), and American Radium Society (ARS). I am also a member of several co-operative groups including: Radiation Therapy Oncology Group (RTOG), Proton Collaborative Group (PCG), and Children’s Oncology Group (COG). I also serve as an active peer reviewer for several oncology focused journals, including the Journal of Clinical Oncology and International Journal of Radiation Oncology, Biology, and Physics.